10,000
Participants
Start Date
October 1, 2019
Primary Completion Date
October 1, 2029
Study Completion Date
October 1, 2029
Plasma sample collection
Collect at least two plasma samples
Roswell Park, Buffalo
Mayo Clinic, Jacksonville
Florida Cancer Specialist and Research Institute, Orlando
Protean Biodiagnosics, Orlando
University of Miami, Miami
Birmingham VAHCS, Birmingham
West Clinic, Germantown
Helen Nassif Community Cancer Center, Cedar Rapids
Northwest Community Healthcare, Rolling Meadows
Thoraxklinik Heidelberg gGmbH, Heidelberg
151-Christus Health St. Michael, Texarkana
Michael E. Debakey VA Medical Center, Houston
Asklepois, Gauting
Rutgers Cancer Institute, New Brunswick
Haemek Medical Center, Afula
Barzilai Medical Center, Ashkelon
Soroka Medical Center, Beersheba
Shamir Medical Center, Be’er Ya‘aqov
Bnai Zion Medical Center, Haifa
Rambam Medical Center, Haifa
Hadassah Medcial Center, Jerusalem
Meir medical center, Kfar Saba
Rabin Medical Center, Petah Tikva
Kaplan Medical Center, Rehovot
Assuta Medical Cetner, Tel Aviv
Sheba Medical Center, Tel Aviv
Sourasky Medical Center, Tel Aviv
Sheba medical center, Tel Litwinsky
044 Hospital Universitario Virgen Macarena, Seville
Aberdeen Royal Infirmary, Aberdeen
Royal Bournemouth General Hospital, Bournemouth
Cheltenham General Hospital, Cheltenham
Mount Vernon Cancer Centre, Northwood
The Shrewsbury and Telford Hospital, Shrewsbury
Lister Hospital, Stevenage
Swansea Bay UHB Singleton Hospital, Swansea
Torbay Hospital, Torquay
Bradford Teaching Hospitals, Bradford
Withybush Hospital, Haverfordwest
South Tyneside, South Shields
Sunderland Royal Hospital, Sunderland
Lead Sponsor
OncoHost Ltd.
INDUSTRY